Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2024 ∙ Abate, B. B. Tilahun, B. D. Yayeh, B. M.
Global COVID-19 vaccine acceptance level and its determinants: an umbrella review
All age groups COVID-19 Acceptance
Rating:
Not applicable
2024 ∙ Law, M. C. Chiu, P. K. F.
Global COVID-19 vaccine hesitancy among elderly: A systematic review
Adults Older adults COVID-19 Acceptance
Rating:
Not applicable
2024 ∙ Abuawwad, M. T. Taha, M. J. J. Taha, A. J. Kozaa, Y. A. Falah, O. Abuawwad, I. T. Hammad, E. M. Mahmoud, A. A. Aladawi, M. Serhan, H. A.
Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports
Adults Older adults COVID-19 Safety
Rating:
Critically low
2024 ∙ Censi, S. Bisaccia, G. Gallina, S. Tomassini, V. Uncini, A.
Guillain-Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis
All age groups COVID-19 Safety
Rating:
Critically low
2024 ∙ Hadhiah, K. Alhashim, A. Al-Dandan, H. A. Alhassan, E. Alqarni, A. M. Memish, A. A. A. Alabdali, M.
Guillain-Barré syndrome post-SARS-CoV-2 vaccine: a systematic review and data analysis on its clinical, laboratory, electrophysiological, and radiological features
Adults Older adults COVID-19 Safety
Rating:
Critically low
2024 ∙ Mitsikostas, D. D. Caronna, E. De Tommaso, M. Deligianni, C. I. Ekizoglu, E. Bolay, H. Göbel, C. H. Kristoffersen, E. S. Lampl, C. Moro, E. Pozo-Rosich, P. Sellner, J. Terwindt, G. Sieira, P. I.
Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review
Adults Older adults COVID-19 Safety
Rating:
Critically low
2024 ∙ Asante, M. A. Michelsen, M. E. Balakumar, M. M. Kumburegama, B. Sharifan, A. Thomsen, A. R. Korang, S. K. Gluud, C. Menon, S.
Heterologous versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
All age groups COVID-19 Efficacy/effectiveness Administration Safety
Rating:
Low
2024 ∙ Alpeza, F. Avermark, H. Gobbo, E. Herzig van Wees, S.
How has co-design been used to address vaccine hesitancy globally? A systematic review
All age groups Human papillomavirus (HPV) COVID-19 Acceptance
Rating:
Not applicable
2024 ∙ Herieka, H. Babalis, D. Tzala, E. Budhathoki, S. Johnson, N. A.
How inclusive were UK-based randomised controlled trials of COVID-19 vaccines? A systematic review investigating enrolment of Black adults and adult ethnic minorities
Europe United Kingdom All age groups COVID-19 Coverage Ethical issues
Rating:
Not applicable
2024 ∙ Li, X. Z. Li, Y. W. Huang, C. Y. Liu, J. L. Liu, R. B. Zhang, Z. X. Yan, J. Z. Zhang, C.
Humoral immunity and safety of respiratory virus vaccines in systemic lupus erythematosus population: a meta-analysis based on twenty-five observational studies
Adults Older adults COVID-19 Influenza Efficacy/effectiveness Safety
Rating:
Critically low
Loading...